All Type of News
KMA, "We will continue lawsuits til the end”
When it comes to the Association of Korean Medicine(AKOM) which changed its English name to a similar one of the Korean Medical Association(KMA), the KMA is planning to push forward with lawsuits against it.
The AKO...
Celltrion’s ‘Remsima’ approve from U.S. FDA, challenging KRW 20 trillion market
Celltrion announced acquisition of U.S. sales approval of the first biosimilar antibody Remsima from the U.S. Food and Drug Administration(hereinafter referring to FDA) on April 5(local time).
The FDA particularly ap...
Korea-Mexico USD 23.5 billion healthcare industry opened
The government put efforts to support entry of the pharmaceutical industry into Mexico for the ‘2nd Kanarb’ legend.
Taking the President Geun-hye Park’s visit to Mexico as an opportunity, the Ministry of Health and ...
Samsung Bioepis to file ‘Humira’ patent nullification lawsuit
Samsung Bioepis filed a lawsuit to nullify a patent against a global pharmaceutical company Abbvie in the U.K.
The reason for the lawsuit is that Abbvie encountering the patent expiration of ‘Humira,’ a rheumatoid ar...
Full of Chinese tourists in Jeju island, visiting pharmacies
Although the 3rd and 4th of April were days that have a relatively small number of tourists in the Jeju island since they were Sunday and Monday, Chinese tourists – also known as Youkers – could easily be seen in majo...
While owner-like CEOs leave, ‘real owners’ come in front
Vice President Won-bae Kim(69) at Dong-A ST is the first CEO who used to be a R&D head in the pharmaceutical industry. After entering Dong-A Pharm in 1974, he has worked as a specialist in R&D for more than 40 years, ...
Green Cross starts to export tetravalent influenza vaccinesOn the 5th, Green Cross(President Eun-cheol Huh) announced acquisition of product approval of ‘GCFLU QUADRIVALENT INJ,’ a tetravalent influenza vaccine 0.5ml vial, from the Mini...
|
Listed pharmaceutical companies’ average annual salary, KRW 54.3 million
It was surveyed employees in listed pharmaceutical companies receive KRW 54 million annual salaries on average.
It was also observed the salary gap between men and women is KRW 15.8 million as estimating KRW 58 mill...
Samsung Bioepis receives positive evaluations for ‘Flixabi’ from CHMP
On the 2nd, Samsung Bioepis announced it received positive opinions from the European Medicines Agency(EMA) and the Committee for Medicinal Products for Human Use(CHMP) for its autoimmune disease treatment Flixabi.
F...
Big pharmaceutical companies’ CEOs visits to Korea are glad, yet not big deals
In this year, decision makers of global pharmaceutical companies, such as presidents and CEOs, have visited Korea in a series.
They all are from well-known pharmaceutical companies, such as Lilly, Beohringer Ingelhe...
